Cyclo Therapeutics, Inc. Completes Merger with Applied Molecular Transport Inc.
Combined company operating as Cyclo Therapeutics with primary focus on advancing Trappsol® Cyclo™ for the treatment of Niemann-Pick Disease Type C1 (NPC1) Cash runway extended into 2H 2024 with ap...